Lesion-to-Liver SUVmax Ratio to Improve the Prognostic Value of the End of Treatment PET/CT in Diffuse Large B-Cell Lymphoma

Background: Diffuse large B-cell lymphoma (DLBCL) is the most common non-Hodgkin lymphoma worldwide. After first-line therapy, 30–40% of patients relapse or experiment with refractory disease. 18F-FDG PET/CT represents a validated diagnostic tool in post-treatment evaluation of FDG-avid lymphoma, an...

Descripción completa

Detalles Bibliográficos
Autores principales: Ferrari, Cristina, Pisani, Antonio Rosario, Masi, Tamara, Santo, Giulia, Mammucci, Paolo, Rubini, Dino, Sardaro, Angela, Rubini, Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9573341/
https://www.ncbi.nlm.nih.gov/pubmed/36233406
http://dx.doi.org/10.3390/jcm11195541

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9573341/
https://www.ncbi.nlm.nih.gov/pubmed/36233406
http://dx.doi.org/10.3390/jcm11195541

Ejemplares similares